Helix BioPharma Corp. (TSX:HBP)
1.400
+0.030 (2.19%)
Jul 3, 2026, 12:37 PM EST
Helix BioPharma Market Cap
Helix BioPharma has a market cap or net worth of CAD 106.93 million as of July 6, 2026. Its market cap has increased by 152.09% in one year.
Market Cap
106.93M
Enterprise Value
104.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.40
Market Cap Chart
Since August 15, 1995, Helix BioPharma's market cap has increased from 9.38M to 106.93M, an increase of 1,039.56%. That is a compound annual growth rate of 8.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 106.93M | -40.93% |
| Dec 31, 2025 | 181.02M | 314.90% |
| Dec 31, 2024 | 43.63M | -4.12% |
| Dec 29, 2023 | 45.50M | 5.81% |
| Dec 30, 2022 | 43.00M | 0.61% |
| Dec 31, 2021 | 42.74M | -36.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Satellos Bioscience | 227.27M |
| Eastwood Bio-Medical Canada | 67.51M |
| ME Therapeutics Holdings | 59.80M |
| Telescope Innovations | 57.37M |
| NurExone Biologic | 51.18M |
| Sernova Biotherapeutics | 49.09M |
| MedMira | 45.61M |
| Microbix Biosystems | 41.33M |